IRIS
SOLINAS, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.623
AS - Asia 2.783
EU - Europa 1.827
SA - Sud America 1.436
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 11
Totale 10.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.533
BR - Brasile 1.258
SG - Singapore 1.106
CN - Cina 974
UA - Ucraina 700
DE - Germania 255
SE - Svezia 235
HK - Hong Kong 224
IT - Italia 182
VN - Vietnam 175
FI - Finlandia 110
FR - Francia 109
GB - Regno Unito 95
AR - Argentina 65
IN - India 49
TR - Turchia 39
BD - Bangladesh 35
CA - Canada 30
RU - Federazione Russa 30
IQ - Iraq 28
UZ - Uzbekistan 27
MX - Messico 26
VE - Venezuela 26
ZA - Sudafrica 24
CO - Colombia 22
EC - Ecuador 22
JP - Giappone 21
PK - Pakistan 20
BE - Belgio 19
MA - Marocco 19
NL - Olanda 14
CL - Cile 13
PL - Polonia 13
AE - Emirati Arabi Uniti 11
AU - Australia 11
DZ - Algeria 11
TN - Tunisia 11
ES - Italia 10
JM - Giamaica 9
PE - Perù 9
PY - Paraguay 9
ID - Indonesia 8
KE - Kenya 8
RO - Romania 8
HN - Honduras 7
AZ - Azerbaigian 6
NP - Nepal 6
OM - Oman 6
PS - Palestinian Territory 6
UY - Uruguay 6
AT - Austria 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
IE - Irlanda 5
JO - Giordania 5
BG - Bulgaria 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
LT - Lituania 4
MY - Malesia 4
AL - Albania 3
AO - Angola 3
BW - Botswana 3
CR - Costa Rica 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PA - Panama 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
KR - Corea 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
SD - Sudan 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CH - Svizzera 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
Totale 10.766
Salva come PNG Salva come JPEG
Città #
Dallas 1.054
Chandler 630
Singapore 575
Jacksonville 420
San Jose 313
Hong Kong 224
Princeton 214
Ashburn 194
Nanjing 181
Dearborn 157
Beijing 129
Council Bluffs 129
Columbus 110
São Paulo 106
Wilmington 105
Lauterbourg 93
Ann Arbor 67
Nanchang 67
Shanghai 65
Boardman 64
Ho Chi Minh City 64
Los Angeles 56
Santa Clara 50
Hanoi 41
Hebei 40
Shenyang 34
Woodbridge 34
Changsha 31
Tianjin 31
Andover 29
Brasília 29
Rio de Janeiro 29
Belo Horizonte 28
Jiaxing 26
Sassari 26
Buffalo 23
Tashkent 22
Hangzhou 21
Tokyo 21
Porto Alegre 19
Brussels 18
Kunming 17
New York 17
Norwalk 17
Jinan 16
Johannesburg 15
Curitiba 14
Baghdad 13
Toronto 13
Uberlândia 13
Campinas 12
Frankfurt am Main 12
Goiânia 12
Amsterdam 11
Chennai 11
Naples 11
Orem 11
Warsaw 11
Betim 10
Ribeirão Preto 10
Salvador 10
Sorocaba 10
Atlanta 9
Caruaru 9
Caxias do Sul 9
Da Nang 9
Fortaleza 9
Nuremberg 9
Phoenix 9
Quito 9
Santo André 9
Denver 8
Florence 8
Guarulhos 8
Haiphong 8
Marrùbiu 8
Medellín 8
Munich 8
Santiago 8
Seattle 8
São Bernardo do Campo 8
Auburn Hills 7
Bari 7
Brooklyn 7
Contagem 7
Duque de Caxias 7
Joinville 7
Lahore 7
London 7
Milan 7
Montreal 7
Ningbo 7
Poplar 7
Recife 7
Rome 7
São José dos Pinhais 7
Aracaju 6
Asunción 6
Baku 6
Casablanca 6
Totale 6.125
Salva come PNG Salva come JPEG
Nome #
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 189
Acute hepatitis with bridging necrosis due to hydralazine intake. Report of a case 167
ARFI (acoustic radiation force impulse imaging) elastography in the liver fibrosis evaluation in HCV correlated chronic liver disease 159
CHANGES OF SERUM 2-5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS C 149
Skin Reaction in Antiviral therapy for Chronic Hepatitis C: A role for Polyethylene Glycol Interferon? 148
Autoimmunity in interferon treated patients with viral chronic liver disease of different etiologies 147
Alteration in thyrotropin (TSH), Prolactin (PRL) and Growth Hormone (GH) secretions in chronic alcoholism and in liver cirrhosis. 139
A 15 year old girl with fever, jaundice, haemolysis, and sudden clinical deterioration 138
Changes of serum 2-5 olygoadenylate synthetase during interferon treatmnet of chronic hepatitis C 137
Alterazioni degli indici di funzionalità tiroidea nelle epatopatie croniche. 137
ASSESSMENT OF VARICEAL PRESSURE WITH AN ENDOSCOPIC BALLOOON: EFFECTS OF PHARMACOLOGICAL THERAPY 136
A randomized controlled trial of interferon alpha-2b as therapy for chronic non-A, non-B hepatitis 134
Alpha-fetoprotein and Hepatitis B Virus infection in chronic liver disease 132
Antibody to Hepatitis B Surface Antigen in chronic liver disease 132
Autoantibodies and response to alpha interferon in patients with chronic viral hepatitis 131
The role of pre-coreHBV mutants on the long-term outcome of chronic HBV hepatitis 129
Alanine amino-transferase, Alpha-fetoprotein, hepatocellular necrosis and regeneration in chronic liver disease 129
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients 128
Aspetti di terapia delle epatiti croniche da virus B e non-A,non-B 126
CARRIER DETECTION AND EARLY DIAGNOSIS OF WILSON'S DISEASE BY RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS 125
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 124
Patterns of respnse during therapy with interferon and outcome of of retreatment with interferon plus ribavirin 122
Chronic liver disease, alcohol consumption and HBsAg antigen in Italy: a multi-regional control study 121
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas 121
Lichen planus associated with anti-liver-kidney mocrosome-positive chronic active hepatitis and hyperthyroidism 120
Alanic transferase, Alphafetoprotein, hepatocellular necrosis and regeneration in chronic liver disease. 119
Interferon therapy for chronic hepatitis C 117
T lymphocyte subsets in parenteral and non-parenteral heroin abusers in Britain 116
Course of patients coinfected with HIV and hepatotropic viruses 115
Changes of serum 2-5- olygoadenilate synthetase during interferon therapy in patients with chronic HCV hepatitis 114
Aspetti della diagnostica delle infezioni croniche da virus dell'epatite B 114
The tumour microenvironment and immune milieu of cholangiocarcinoma 114
Reazioni cutanee da farmaco: manifestazione eczema-like in corso di terapia antivirale per epatite da virus C 112
Porto-hepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitits C virus infection 111
Programmed death ligand 1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer? 111
The problem of cancer diagnosis in thyroid nodules: a study in an endemic area for goiter in North Sardinia 110
Thymic hormones in the treatment of chronic HBV infection 109
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 109
PRE-CORE MUTANTS AND RESPONSIVENESS TO INTERFERON IN CHRONIC HEPATITIS B 107
Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin 106
Cognitive dysfunction and hepatitis C virus infection 106
Espressione immunomorfologica e quadri sierologici dell'epatite da virus B 105
Effect of different doses (1,000,000 AND 3,000,000 units ) od interferon alfa on the ALT levels of nonAnonB patients 104
Lichen planus, chronic liver disease and immunologic involvement 103
Early diagnosis of Wilsonìs Disease by DNA analysis 102
Systemic amyloidosis rapidly progressing to liver failure and hepato-renal syndrome. Report of a case 102
Systemic lupus erythematosus in a patient with chronic hepatitis C 100
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) 99
Growth hormone (GH) secretion in hepatic encephalopathy 98
The long lasting course of chronic hepatitis C infected patients treated with interferon alfa-2b 98
Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A, non-B hepatitis. A randomized controlled trial 97
Identification of Mycobacterium avium subsp paratuberculosis in biopsy specimens from patients with Crohn\'s disease identified by in situ hybridization 96
Impaired thyrotropin (TSH) response to thyrotropin releasing hormone (TRH) in hepatic encephalopathy 96
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study 96
Epatite cronica in pazienti con coinfezione multipla HIV-Virus epatotropi 95
Twenty-four novel mutations in Wilson Disease of predomintaly Italian origin 94
Pituitary secretion in hepatic encephalopathy 94
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin-releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 94
Impaired thyrotrophin (TSH) response to thyrotrophin releasing hormone (TRH) in hepatic encephalopathy 94
M. paratuberculosis may cause Crohn’s disease 93
Identification of Mycobacterium avium subp. paratuberculosis in biopsies from patients with Crohn\'s disease identified by in situ hybridization 93
Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection 92
High resolution-magic angle spinning (HR-MAS)-NMR based metabolomic fingerprints of early and recurrent hepatocellular carcinoma 92
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the study of liver transplantation 91
tHE LONG-TERM VARICEAL PRESSURE RESPONSE TO NADOLOL ALONE AND NADOLOL PLUS ISOSORBIDE MONONITRATE 91
us-GUIDED DIRECT TRANS-HEPATIC MEASUREMENT OF THE VENOUS PORTAL GRADIENT: A NEW APPROACH TO EVALUATE PORTAL HYPERTENSION 91
LONG-TERM RESPONSE TO INTERFERON ALFA RE-TREATMENT IN CHRONIC HEPATITIS C 90
Receptors for polymerized human serum albumin 89
MOLECULAR PATHOLOGY AND HAPLOTYPE ANALYSIS OF WILSON DISEASE IN MEDITERRANEAN POPULATIONS 89
HBsAg carrier and liver disease 89
Occurrence of hepatocellular carcinoma and decompensation in Western patients with cirrhosis type B 87
Enfermedad de Erdheim-Chester: reporte de 2 casos 86
Circulating immune complexes during acute viral hepatitis type B: an attempt to detect HBsAg as their antigenic component by means of direct immunofluorescence on Raji cells 86
Immune complexes and complement system in HBsAg positive liver diseases 86
Polymerase chain reaction assay for detection of Hepatitis B Virus DNA in the serum of HBsAg/antiHBe positive subjects 84
TSH secretion in patients with hepatic encephalopathy 83
Free thyroid hormone concentration in chronic alcoholes with liver steatosis. M. Langer, S. Rassu, P.P. 83
Livelli sierici delle frazioni C3 e C4 del complemento in corso di epatopatia 82
Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemia 82
Interferon alpha therapy in sicilian and sardinan polytransfused thalassemic patients with chronic hepatitis C 82
Sex steroids and sex hormone binding globulin in males with chronic alcoholism and liver cirrhosis 82
Marcatori del virus dell'epatite B, stato della replicazione virale condizioni cliniche associate 81
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alpha 2b 81
Hepatic hemodynamics and liver function: comparison of a six month course of nadolol and octreotide 81
Hepatitis D Virus infection in parenteral drug abusers 80
High resolution-magic angle spinning (HR-MAS) NMR-based metabolomic fingerprinting of early and recurrent hepatocellular carcinoma 79
Imaging e valutazione emodinamica nella diagnostica epatologica. Emodinamica epatica invasiva 79
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary centres in Europe 78
Free thyroid hormones and chronic liver disease 78
Characterization of Hepatitis B Virus Core region DNA in circulating Dane particles using direct sequencing of single stranded template generated by asymmetric polymerase chain reaction 78
PROLONGED TREATMENT (2YEARS) WITH DIFFERENT DOSES (3 VS 6 MU) OF INTERFERON ALFA2B FOR CHRONIC HEPATITIS C 78
Recurrent Hepatitis Delta Virus infection after liver transplantation 77
The predictive value of free thyroid hormones in patients with liver cirrhosis 76
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis 76
Correlazione tra aspetti istologici e valori sierici di alfafetoproteina in epatopatie croniche HBV positive. 76
Longitudinal study of anti-HBe and DNA polymerase positive patients with chronic liver disease 75
Serum Markers of HBV infection and alphafetorprotein in chronic non malignant liver disease. 72
Correlazione tra aspetti istologici e valori serici di AFP in epatopatie croniche HBV positive 72
Il trattamento con levamisolo in corso di epatite cronica attiva 72
Follow-up study of alpha-fetoprotein in chronic liver disease. Its role in the detection of primary hepatocellular carcinoma. 71
Totale 10.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022410 0 1 3 2 3 5 37 34 52 14 50 209
2022/20231.182 113 58 15 183 155 206 0 162 214 12 34 30
2023/2024180 66 21 5 10 23 1 0 9 0 0 9 36
2024/20252.595 24 15 175 43 119 57 206 524 950 334 85 63
2025/20263.375 91 907 328 503 230 312 450 164 188 117 69 16
2026/2027352 74 278 0 0 0 0 0 0 0 0 0 0
Totale 10.795